The AJP Podcast

Australian Journal of Pharmacy

The podcast by pharmacists, for pharmacists, brought to you by the AJP. Each episode, join a diverse panel of pharmacists from all settings and experience levels discussing topics that affect pharmacists in day to day practice – such as ability & gender diversity in pharmacy, and medicinal cannabis.

  1. May 20

    ‘They become more and more sophisticated over time’

    AJP Podcast host Carlene McMaugh discusses cybersecurity in 2026 – including why pharmacists need to consider themselves data stewards She sits down with PSA’s digital health lead and pharmacist Jarrod McMaugh to discuss everything from why criminals target small businesses, how to tell the difference between a legitimate communication from a GP or wholesaler and a data theft attempt, and pharmacists’ obligations to their patients when it comes to privacy. The two discuss why the greater amount of data now collected and shared could leave a “back door” open to cyber threats – and why you should never pay a ransom if you’ve been targeted. Highlights include 01:03 – Why is community pharmacy a high-value target for cybercriminals? 02:52 – Protection and prevention 06:25 – The common weak links in pharmacy digital infrastructure 07:58 – Spot the difference: legitimate requests and data theft attempts 10:31 – Pharmacies’ responsibilities under the Australian Privacy Principle 11 13:28 – Legal and professional obligations if a breach occurs 20:34 – “Every health service in the country must have a policy around their access to My Health Records.” 23:33 – Privacy considerations around the Pharmacists Shared Medicines List 27:01 – The top three non-negotiable digital hygiene habits 28:53 – The role of software vendors 31:49 – How do shared records raise privacy and cyber threat concerns? 33:42 – The role of professional indemnity insurers 36:21 – The role of the PSA You can access the full transcript of this podcast here. While we endeavour to ensure all important words and phrases are correct, please note there may be some minor inaccuracies in the transcription. ACCESS PODCAST TRANSCRIPT Go here for the full list of active AJP podcasts. These can also be accessed via Apple Podcasts and Spotify  Carlene McMaugh

    38 min
  2. May 6

    Frontline workers critical to AI use in healthcare

    Decisions around the adoption of AI in healthcare need input from those who will be using it, hospital pharmacist Ella Shearing says  AJP Podcast host Carlene McMaugh sits down with clinical pharmacist Ella Shearing, of Locumate, to discuss the use of artificial intelligence (AI) in pharmacy.  A survey conducted by Shearing at a Sydney hospital found pharmacists were receptive to using the new technology (2 minutes 30), but understanding of AI was mixed (3:26).   Shearing noted that while AI is already being used by pharmacists and other health practitioners for administrative tasks (7:03), decisions regarding how it is implemented need to take the views of frontline workers into account (16:13).  “Just because we can adopt AI tools doesn’t mean we should,” Shearing told McMaugh (17:12).   Highlights include:  3:35 – Environmental costs of AI not well understood  9:25 – Barriers to taking AI into the clinical space  10:41 – Lack of transparency around AI software fuels hesitancy among some pharmacists  13:16 – High costs mean AI is unlikely to replace existing drug interaction software  14:25 – Integrating AI into electronic medical record systems (EMRs) “could be quite useful”  21:15 – AI could be used to generate medication charts for patients to take home and for providing information about Webster pack changes with patients’ community pharmacies  22:15 – The best way to learn about AI is to use it  25:12: Development of guidelines and policies will be key to ensuring the safe and ethical use of AI in healthcare settings  26:14 – Pharmacists currently using AI are conservative about how they use it.   You can access the full transcript of this podcast here. While we endeavour to ensure all important words and phrases are correct, please note there may be some minor inaccuracies in the transcription. ACCESS PODCAST TRANSCRIPT Go here for the full list of active AJP podcasts. These can also be accessed via Apple Podcasts and Spotify  Carlene McMaugh

    30 min
  3. Apr 22

    ‘Step fully into your role as a prevention leader’

    Vaccination will always be the “inaugural proof point for full scope,” says “the Vaccination Pharmacist” In this episode of the AJP Podcast, host Carlene McMaugh sits down with Anna Theophilos, who takes listeners through her journey into an educator on social media – and how to cut through misinformation about vaccines. Discussing the importance of communicating about the risks of influenza, especially for people aged over 50, and RSV, Theophilos says that the public already know and trust pharmacists as vaccinators. “What needs to shift is not necessarily public perception, but it’s the system’s willingness to formally recognise what pharmacists already are, which we are immunisation leaders,” she says – noting that this also means appropriate remuneration and a new look at vaccinating outside community pharmacies. Highlights include 01:23 – Theophilos’ mission 02:10 – From a “very sad Facebook page” to effective social media communication 04:30 – Where Theophilos gets ideas for content 05:45 – “I actually think the public is already ahead of the system on this one.” 09:04 – How she plans to work with the PSA to advocate for legislative change to support pharmacist immunisers 10:10 – System and funding barriers 12:55 – Work in aged care 14:30 – How can a busy community pharmacy integrate high volume vaccination programs without compromising safety or staff wellbeing? 16:49 – Ensuring financial viability 19:38 – High-level discussions 21:40 – Collaborating with local GPs 26:07 – “Vaccination will always be the inaugural proof point for full scope.” 28:19 – Advice for ECPs 30:51 – The most common vaccine myth Theophilos debunks 32:32 – “I’d make every vaccine funded.” 33:27 – A call to action You can access the full transcript of this podcast here. While we endeavour to ensure all important words and phrases are correct, please note there may be some minor inaccuracies in the transcription. ACCESS PODCAST TRANSCRIPT Go here for the full list of active AJP podcasts. These can also be accessed via Apple Podcasts and Spotify  Carlene McMaugh

    35 min
  4. Apr 8

    ‘How do you approach those conversations?’

    Do pharmacists have a bigger role to play recognising and supporting patients with mental health concerns? The AJP Podcast discusses the matter with Claire O’Reilly Australia’s pharmacists have a frontline role in triaging patients who are struggling, but more training is needed across the profession, the AJP Podcast has heard.  Pharmacist and Associate Professor at the University of Sydney School of Pharmacy, Claire O’Reilly, has been a researching the evolving role of pharmacists in the mental health space for some time. She has become an advocate for further education and training.  “I think we do need to really work at improving the communication skills to make people feel comfortable,” she told Carlene McMaugh.  “If someone does say that they’re not okay, then what? That’s the critical next step.” Other highlights include:  4.01: A distressing incident that highlighted the need for further education.  5.58: The importance of mental health training.  10.03: Signs or cues someone may be struggling.  15.00: Creating a safe, non-judgmental space.  19.19: Medications management.  21.32: Essential steps pharmacists can take.  23.02: Referral services.  26.00: How pharmacists can manage their own mental health and burnout.  Pharmacists can contact the Pharmacists’ Support Service (PSS) on 1300 244 910 for peer support related to the demands of being a pharmacist in Australia. Lifeline is available on 13 11 14. Members can call PDL on 1300 854 838 for support from a professional officer. For urgent assistance or in an emergency please do not hesitate to contact emergency services on 000. You can access the full transcript of this podcast here. While we endeavour to ensure all important words and phrases are correct, please note there may be some minor inaccuracies in the transcription. ACCESS PODCAST TRANSCRIPT Go here for the full list of active AJP podcasts. These can also be accessed via Apple Podcasts and Spotify  Carlene McMaugh

    32 min
  5. Mar 25

    Scope legislation: pushing the government

    “Legislation and practice aren’t necessarily keeping up with the universities,” says a leading pharmacy student, discussing the future of the sector Sebastian Harper, national president at the National Australian Pharmacy Students’ Association (NAPSA), chats with AJP Podcast host Carlene McMaugh about scope of practice, the importance of making pharmacy friends and placement poverty. Harper says that universities are already ahead of the game when it comes to expansion of pharmacy practice. “I think things like legislation and practise aren’t necessarily keeping up with the universities,” he says. “The unis are pretty much almost there with having graduates ready to get out there and adapt to the new scope of practice for pharmacists, but it’s the legislation, it’s the scope of practice programs.” While some states are ahead of others, “some are falling a bit behind,” he warns. “And it’s actually, I think, students that are really ready to undertake these services. Obviously, we do need that extra training, but compared to the pharmacists who graduated 20 years ago, not as much extra training and not as much extra knowledge and skill with what we’re learning. “It’s really about the profession actually continuing to push the government, continuing to push each other to make sure that practise actually is adapting to what students are ready to do from graduation and from when they finish internship.” Highlights include: 00:56 – Discussing placement poverty with decision-makers 02:45 – Talking to patients in full scope consultations 05:42 – Skill gaps between study and practice 07:21 – Stories from NAPSA Congress 09:14 – The surprise changes of 2025 11:00 – NAPSA goals 14:23 – “Students don’t necessarily realise the power that they have in their profession.” 17:28 – Core competencies needed for future success 21:29 – NAPSA’s long-term vision 25:32 – The most-needed skill in 2026 26:55 – A deeper look at placement poverty 29:21 – Key questions when interviewing for an internship 32:31 – Staying centred during internship 34:48 – “Get involved in NAPSA.” You can access the full transcript of this podcast here. While we endeavour to ensure all important words and phrases are correct, please note there may be some minor inaccuracies in the transcription. ACCESS PODCAST TRANSCRIPT Go here for the full list of active AJP podcasts. These can also be accessed via Apple Podcasts and Spotify  Carlene McMaugh

  6. Mar 11

    ‘We’ll be strongly advocating for things like removal of caps’

    PSA’s new president flags changes to the profession, with priorities including the negotiation of the pharmacy programs agreement, the new Code of Ethics and the College transition AJP podcast host Carlene McMaugh sits down for a chat with Pharmaceutical Society of Australia national president Mark Naunton, who says that he has “great confidence” in how the agreement’s negotiations are taking place. “There’s a number of things that we’ll be advocating strongly for, and our credentialed pharmacist need to know that they are at the forefront of our minds. “When we are doing these negotiations, our credentialed pharmacists have a great impact in trying to improve patient safety, which is, as medicine safety is as national health priority area, all pharmacists have a responsibility to do this, but under the first PPA, our credentialed pharmacist, those pharmacists doing HMRs, RMMRs, they do need special attention. “There’s been years where they’ve had no increase in their pay. They’re limited by the amount of work they can do, and we know that they do great work, but not all patients are getting benefit from these because there’s caps, for example, on the amount of HMRs that they can do. “So we’ll be strongly advocating for things like removal of caps, indexation of payments, back pay for programs that have not had increases in pay over the last five or six years.’ Highlights include: 01:36 – The sector’s biggest recent achievement 03:36 – How is PSA supporting upskilling as scope expands? 08:36 – Unifying the profession 11:12 – The impact of work on focus areas like palliative care, mental health first aid and vaping reform 14:18 – The Code of Ethics review 17:13 – Advocating for the funding of professional services 21:43 – Key goals for career pathways 24:02 – Naunton’s plans for his first term 28: 23 – PSA’s 2025 achievements 31:02 – What does 2026 hold in store for pharmacists and the PSA? You can access the full transcript of this podcast here. While we endeavour to ensure all important words and phrases are correct, please note there may be some minor inaccuracies in the transcription. ACCESS PODCAST TRANSCRIPT Go here for the full list of active AJP podcasts. These can also be accessed via Apple Podcasts and Spotify  Carlene McMaugh

    36 min
  7. Feb 25

    AJP Podcast: ‘We’re not talking about robo pharmacists’

    Is AI likely to result in a dystopian future for health professionals and patients – or could it be used to free up more hours in the day for pharmacists to do their jobs? AJP Podcast host Carlene McMaugh sits down with Michael Bakker, chief pharmacy information officer for SA Pharmacy, about the barriers to digital transformation for pharmacists, overcoming resistance to change, and what the future might look like. The pair discuss common misconceptions about AI – including that it could replace key health workers such as pharmacists. “We’re not talking about robo pharmacists, right?” says Bakker. “There’s tasks and processes that will be impacted by the advent of AI, but they could also happen with non-AI things. “If we took one task and process just to kind of put it under the microscope, a hospital pharmacy service spends probably about a third of their clinical workforce time on performing medication histories. “And so you could go, ‘well, there’s many different ways that digitally, we could do that a lot better now if we just had better linked data or atomic data around medicines where it’s easy to go, oh, this person’s on perindopril five milligrams once a day, and it’s easy to convert that over to your hospital system. “And you can see the dispensing record for the patient, and if we had all of the dispensing records and prescribing records going up to My Health Record, it’s pretty easy to conceptualise a way where you go, ‘well, I can see that they’re on that regularly. I’m just going to convert that to their hospital medicine and just continue that there’. “That could be done without any AI. “The technology is not the barrier there. It’s the investment and the prioritisation of that development work that needs to be there and having the high quality data sitting in my health record to be able to reutilise it. “They might sound like big things, but they’re quite small. It’s not like we’re waiting for some technology to come along that doesn’t exist yet. “The AI ones that I think scare people is around the decision making and to be able to decide what to do, and the door’s starting to open there as to what that future state might look like to my network.” Bakker told McMaugh he had recently posted to LinkedIn about the United States having opened the policy door to having AI agents being able to prescribe for patients. “It’s just a very interesting concept that it’s not an automated thing that they can do this, they need to undergo all of their approvals through the FDA.” While he is not aware of this happening in practice, Bakker says it poses the question: what would this look like? “Is that going to be an AI agent is taking an action on behalf of say a prescriber when they’re talking to their patient. So they’re saying, ‘I’m going to give you amoxicillin 500mg four times a day’ and then it’s just going to generate the prescription. “And so that’s kind of minimally invasive and risky. You have to prove quality and things like that so that it’s not going to mistake the drug name or anything; or is it going to be far more dystopian where it’s going to diagnose and take action to prescribe a recommended therapy for a patient, which is a little bit more scary? “So not everything is a one or a zero or a yes and a no. “There’s lots of gradients in between in there, and so I think people get very alarmed and rightfully so as to what the really crazy dystopian future might look like and what’s my role going to be in that if these things come about. “But there’s a lot of work in between where we can just see the chipping away at tasks and processes through better technology, that are things that take an enormous amount of time, as good as the pharmacy workforce is at doing these types of things thoroughly… “If we were reviewing information that was presented to us that was kind of curated so that we don’t have to go and do a preliminary history for a patient, then go into the patient room and validate it with them, then come out, reconcile it with what they’re actually on and then get it changed, we can walk straight in going, ‘well, I can see what you’re normally taking, but can you help me understand how you’re actually using these on a day to day?’ “You could be saving an hour a day for a clinical pharmacist that can be redirected into other tasks.” Highlights include: 00:56 – “Digital maturity can mean lots of things.” 02:24 – Getting started 03:27 – Barriers to digital transformation 06:44 – Insights from developing the Australian practice standard for pharmacy informatics 10:03 – How is AI currently being used to manage medicine safety, especially in rural or remote areas? 13:43 – No robo pharmacists 19:22 – How can pharmacists who are not tech experts start to build their digital literacy and become effective champions for changing their workplaces? 22:23 – Retaining the human touch 25:44 – Encouraging buy-in, including from pharmacists who have concerns 28:20 – “Soft skills are crucial.” 29:51 – Using AI to build a strong business case for new initiatives 32:56 – The most exciting emerging AI and digital trends 34:53 – As pharmacy workflows become more digitalised, what new types of dispensing and prescribing errors are we seeing and how can we mitigate them? 37:51 – “Get great at pharmacy first at all areas of pharmacy.” 39:27 – How could pharmacy look in 10 to 15 years? 41:46 – Learning from other sectors You can access the full transcript of this podcast here. While we endeavour to ensure all important words and phrases are correct, please note there may be some minor inaccuracies in the transcription. ACCESS PODCAST TRANSCRIPT Go here for the full list of active AJP podcasts. These can also be accessed via Apple Podcasts and Spotify  Carlene McMaugh

    43 min
  8. Feb 11

    ‘Total reliance on the supply model will not sustain our industry’

    FIP president pays tribute to Australia’s pharmacy practice model, as international jurisdictions champion pharmacist scope Paul Sinclair, the first Australian president of the International Pharmaceutical Federation (FIP) sat down with AJP Podcast host Carlene McMaugh to talk about the pharmacy workforce, challenges like antimicrobial resistance and how best to use AI in health care. There are many positives boosting the sector right now, Sinclair said, including how the pandemic improved pharmacy’s visibility and moves towards full scope of practice. When McMaugh asked Sinclair whether he saw elements of the Australian model – such as expanded scope under the Community Pharmacy Agreement – being eyed by other countries, he replied, “Absolutely”. “As recently as two months ago, the Irish government signed a pharmacy agreement with the Irish Pharmacy Union on behalf of Irish pharmacy to give certainty of remuneration for dispensing and provision of professional services,” Sinclair said. “That very much is in line with the community pharmacy agreements that we have had so successfully implemented here in Australia. “In fact, the PBS, as it operates in Australia, is regarded as the best model for a public private partnership to provide pharmaceutical benefits to the population. “We see across the globe, services such as medication reviews, medication management services, webster packing, pharmacist delivered vaccination, and minor ailment schemes being delivered and funded through community pharmacy. “This is now happening through all of the major developed pharmacy marketplaces, and we are seeing also in FIP’s role, the advocacy of an increased role for pharmacists in emerging pharmacy markets as well in low to middle income countries.” Sinclair said that Australia is “very fortunate” to have a public-private partnership with the government, instead of a fully managed healthcare system as seen in the USA. There, he said, “the payer, normally an insurance company, is focused only on cost rather than health outcomes”. “So the model we have is acknowledged as being world-class, and we are seeing across particularly developed marketplaces where the payer tends to be the government rather than insurance company, models like the community pharmacy agreement being advocated for and being implemented.” Highlights include: 01:03 – “At the moment, the depressing issue is certainly workforce shortages.” 03:43 – The positive outcomes of Covid 05:15 – AMR: a major issue 07:33 – The beauty of the Australian pharmacy practice model 09:20 – FIP’s Global Observatory data 11:26 – “AI is the two letters on everyone’s lips at the moment.” 13:31 – “FIP’s work is centred on creating positive practise environments, safe staffing, fair scheduling, career development, recognition, including mental health support, anti-harassment policies, and psychologically safe spaces.” 15:36 – Integrating pharmacy into diverse global settings 17:08 – Barriers to scope: “It is definitely legislative.” 18:43 – Equity in medicines access and digital health 23:36 – Financial recognition for professional services 25:10 – “The total reliance on the supply model will not sustain our industry going forward.” 31:03 – Advice for young pharmacists 33:11 – FIP’s development goals 34:37 – Hopes for FIP achievement in 2026 37:42 – A legacy for FIP 39:23 – A look back at a “huge” 2025 42:15 – War, conflict and pharmacy – as well as scope and recognition 44:15 – A thank you to pharmacists   You can access the full transcript of this podcast here. While we endeavour to ensure all important words and phrases are correct, please note there may be some minor inaccuracies in the transcription. ACCESS PODCAST TRANSCRIPT Go here for the full list of active AJP podcasts. These can also be accessed via Apple Podcasts and Spotify  Carlene McMaugh

    46 min

About

The podcast by pharmacists, for pharmacists, brought to you by the AJP. Each episode, join a diverse panel of pharmacists from all settings and experience levels discussing topics that affect pharmacists in day to day practice – such as ability & gender diversity in pharmacy, and medicinal cannabis.

You Might Also Like